Gemcitabine Hydrochloride

Spezifikationen

122111-03-9CAS-Nummer

601-823-3EG-Nummer

4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochlorideIUPAC-Name

C9H12ClF2N3O4Chemische Formel

299.66 g/molMolekulargewicht

GEMCITABINE HYDROCHLORIDE; 122111-03-9; Gemcitabine HCl; LY188011 hydrochloride; 2'-Deoxy-2',2'-difluorocytidine monohydrochloride; 2'-deoxy-2',2'-difluorocytidine hydrochloride; Cytidine, 2'-deoxy-2',2'-difluoro-, monohydrochloride; DTXSID3047849; Gemcitabine HCI; Gemcitabine (as hydrochloride); INFUGEM; U347PV74IL; LY-188011 HYDROCHLORIDE; 2',2'-Difluorodeoxycytidine monohydrochloride; DTXCID3027827; CHEBI:31647; NSC613327; RefChem:57768; FF10832; FF 10832; FF-10832; 2'Deoxy-2',2'-Difluorocytidine, Hydrochloride; 1-(2-Oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose, hydrochloride; 601-823-3; Difluorodeoxycytidine Hydrochloride; Gemzar; MFCD01735988; 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one hydrochloride; Gemcitabine (Hydrochloride); 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochloride; CAS-122111-03-9; Gemcitabine hydrochloride [USAN]; C9H12ClF2N3O4; Gemcitabine HCL (Gemzar); LY 188011; UNII-U347PV74IL; 2',2'-Difluoro-2'-deoxycytidine hydrochloride; NCGC00168784-01; Gemzar (TN); AVGEMSI; INLEXZO; Gemcitabine hydrochloride [USAN:USP]; 122111-03-9 (HCl); Inno-D07001; SCHEMBL4366; CHEMBL1637; Gemcitabine hydrochloride CRS; MLS003915643; orb1301102; HY-B0003R; EX-A837; GLXC-05199; 2'-Deoxy-2',2'-difluorocytidine monohydrochloride (beta-isomer); 4-AMINO-1-((2R,4R,5R)-3,3-DIFLUORO-4-HYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL)PYRIMIDIN-2-ONE HYDROCHLORIDE; HY-B0003; Tox21_112644; EBC-13373; Gemcitabine hydrochloride (JAN/USP); HB4199; MSK162384; s1149; GEMCITABINE HYDROCHLORIDE [MI]; AKOS015999730; Tox21_112644_1; CCG-267459; CS-0755; Gemcitabine (hydrochloride) (Standard); GEMCITABINE HYDROCHLORIDE [JAN]; ND09343; Gemcitabine HCl (Gemzar,LY188011)?; GEMCITABINE HYDROCHLORIDE [MART.]; GEMCITABINE HYDROCHLORIDE [VANDF]; NCGC00168784-03; AS-13656; BG164501; GEMCITABINE HYDROCHLORIDE [USP-RS]; GEMCITABINE HYDROCHLORIDE [WHO-DD]; SMR000469146; SY014538; Gemcitabine hydrochloride, >=98% (HPLC); G1745; Gemcitabine hydrochloride - Bio-X trade mark; T6069; Gemcitabine Hydrochloride,Gemzar, LY-188011; D01155; GEMCITABINE HYDROCHLORIDE [EP MONOGRAPH]; GEMCITABINE HYDROCHLORIDE [ORANGE BOOK]; 2'-deoxy-2',2'-difluorocytidine, hydrochloride; EN300-7361886; GEMCITABINE HYDROCHLORIDE [USP MONOGRAPH]; F079926; Q27114559; 2'-Deoxy-2',2'-difluorocytidine--hydrogen chloride (1/1); 2'-DEOXY-2',2'-DIFLUOROCYTIDINE MONOHYDROCHLORIDE (.BETA.-ISOMER); Gemcitabine hydrochloride, European Pharmacopoeia (EP) Reference Standard; Gemcitabine hydrochloride, United States Pharmacopeia (USP) Reference Standard; (2'R,4'R,5'R)-4-Amino-1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyridin-2-one hydrochloride; 2 inverted exclamation mark -Deoxy-2 inverted exclamation mark ,2 inverted exclamation mark -difluorocytidine Hydrochloride; 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-onehydrochloride; 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one hydrochloride; 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one;hydrochloride; Gemcitabin hydrocloridSynonyme